Barclays lifts target for Bruker stock to USD 70.00

Published on 10/17/2026 at 19:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue rose 5.20 percent to USD 838.50 million in the June quarter. Bruker stock costs USD 54.80 on October 16, 2026, down 3.08 percent on Nasdaq.

Analyst target and price context

Barclays analyst Luke Sergott lifted Bruker's target from USD 58.00 to USD 70.00 on October 7, 2026.
Bruker revenue rose 5.20 percent to USD 838.50 million in the second quarter of 2026.
Bruker stock last traded at USD 54.80 on Nasdaq on October 16, 2026 at 4:00 p.m. EDT, down 3.08 percent on the day.
MarketBeat lists November 2, 2026 as Bruker's estimated next earnings date.

BRKR, US1167941087, Illustration mit AI erstellt.

Barclays analyst Luke Sergott raised the price target for Bruker from USD 58.00 to USD 70.00 on October 7, 2026, while keeping an Overweight rating, according to Markets Insider. The Nasdaq-listed stock last traded at USD 54.80 on October 16, 2026 at 4:00 p.m. EDT, down 3.08 percent on the day.

Revenue reached USD 838.50 million

Bruker reported revenue of USD 838.50 million for the second quarter of 2026, an increase of 5.20 percent from the year-earlier period. Adjusted earnings per share reached USD 0.49, beating the Zacks consensus estimate of USD 0.38 by USD 0.11, while revenue fell short of the USD 853.57 million estimate, according to Zacks.

Stock sits below its yearly high

At USD 54.80, Bruker stood USD 12.18 below its 52-week high of USD 66.98 and USD 22.43 above its 52-week low of USD 32.37 on October 16, 2026. Trading volume was 1,674,167 shares, compared with an average of 2,265,785 shares. On October 14, 2026, J.P. Morgan downgraded Bruker to Neutral from Overweight while retaining a USD 70.00 target, as Seeking Alpha reported.

Valuation and next reporting date

Bruker had a market capitalization of USD 8.3 billion on October 16, 2026. Its dividend yield was 0.36 percent, while the negative trailing earnings figure makes a conventional earnings multiple unhelpful. MarketBeat lists November 2, 2026 as the estimated next earnings date.

Comparison with peers

Bruker: minus 3.08 percent, market capitalization USD 8.3 billion

Danaher (NYSE, USD): minus 1.06 percent, P/E 40.68, market capitalization USD 161.0 billion

Thermo Fisher Scientific (NYSE, USD): minus 0.93 percent, P/E 37.12, market capitalization USD 255.1 billion

Price position remains the key signal

Bruker's October 16 close left the stock 18.18 percent below its 52-week high and 69.20 percent above its 52-week low. The one-day decline was steeper than Danaher's 1.06 percent fall and Thermo Fisher's 0.93 percent decline, placing Bruker at the weaker end of this selected life-science-tools comparison.

Bruker last traded at USD 54.80 on Nasdaq on October 16, 2026 at 4:00 p.m. EDT, down 3.08 percent on the day. MarketBeat's calendar gives November 2, 2026 as the estimated next earnings date.